Exhibitors Search

앱파인더테라퓨틱스

Booth no. A60
Exhibition
|
Country
| Korea, South
Address
|47 Heungan-daero 427beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea
Tel
|--
E-mail
| skhan@abfindertrx.com
Exhibits
| PepFc ® A short peptide that has only the pH-dependent FcRn binding ability of Fc developed with our proprietary technology / AbFinder ® Efficient antibody discovery and engineering platform technology created by our own optimized antibody library (Material resource) and diverse antibody discovery and engineering experience (Human resource).
Company Type
|

Exhibitor Information

Next generation revolutionary
biopharmaceutical platform company
AbFinder Therapeutics Co., Ltd. is a R&D company of biopharmaceutics based on innovative platform technologies including "PepFc® platform“, which is the one and only small peptide platform technology replacing Fc of IgG, and "AbFinder® platform“, which is a platform technology carrying out from discovering antibody therapeutics to engineering.

Individual Exhibit/Technology Introduction (Detailed)

  • Product Name : PepFc ® A short peptide that has only the pH-dependent FcRn binding ability of Fc developed with our proprietary technology / AbFinder ® Efficient ant
    PepFc ® A short peptide that has only the pH-dependent FcRn binding ability of Fc developed with our proprietary technology / AbFinder ® Efficient antibody discovery and engineering platform technology created by our own optimized antibody library (Material resource) and diverse antibody discovery and engineering experience (Human resource).
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod
  • Product Name :  
     
    main-prod